Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
This paper describes particular aspects of the marketing of veterinary medicinal products (VMPs) that contain or consist of genetically modified micro-organisms (GMMs) or genetically modified organisms (GMOs). The regulatory requirements and the procedures applied in the European Union for each phase (pre-marketing, authorisation process, and post-authorisation labelling and monitoring) are explained. In most cases VMPs are subject to both pharmaceutical and GMO regulations. In the early stages of the process, before applications for marketing authorisation are submitted, the assessment of clinical trials and experiments in contained areas is principally the responsibility of national authorities. However, the marketing of all VMPs containing or consisting of GMOs must be authorised at European level, although the national authorities are informed and involved in the assessment process.
Moulin
G
G
Agence Française de Sécurité Sanitaire des Aliments/Agence Nationale du Médicament Vétérinaire, La Haute Marche, B.P. 90203, 35302 Fougères, France.
D000818:Animals; D030801:Animals, Genetically Modified; D005060:Europe; D007880:Legislation, Drug; D007886:Legislation, Veterinary; D030781:Organisms, Genetically Modified; D012449:Safety; D019155:Veterinary Drugs
D019155:Veterinary Drugs